Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?

by Clotilde Allavena, Catia Marzolini
Published 2021-10-01

Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France.

by Christine Jacomet, Clotilde Allavena, Fleur Peyrol, Bruno Pereira, Laurence Morand Joubert, Haleh Bagheri, Laurent Cotte, Rodolphe Garaffo, Laurent Gerbaud, Pierre Dellamonica
Published 2015-01-01

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.

by Maxime Hentzien, Cyrille Delpierre, Pascal Pugliese, Clotilde Allavena, Christine Jacomet, Marc-Antoine Valantin, André Cabié, Lise Cuzin, David Rey, Firouzé Bani-Sadr, Moustapha Dramé, Dat’Aids Study Group
Published 2018-01-01

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.

by Isabelle Poizot-Martin, Clotilde Allavena, Claudine Duvivier, Carla Eliana Cano, Francine Guillouet de Salvador, David Rey, Pierre Dellamonica, Lise Cuzin, Antoine Cheret, Bruno Hoen, Dat'AIDS Study Group
Published 2016-01-01

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

by Lise Cuzin, Pascal Pugliese, Clotilde Allavena, David Rey, Catherine Chirouze, Firouzé Bani-Sadr, André Cabié, Thomas Huleux, Isabelle Poizot-Martin, Laurent Cotte, Corinne Isnard Bagnis, Philippe Flandre, Dat’AIDS study group
Published 2017-01-01

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.

by Laurent Cotte, Tristan Ferry, Pascal Pugliese, Marc-Antoine Valantin, Clotilde Allavena, André Cabié, Isabelle Poizot-Martin, David Rey, Claudine Duvivier, Antoine Cheret, Pierre Dellamonica, Pierre Pradat, Jean-Jacques Parienti, Dat’AIDS study group
Published 2017-01-01

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

by Pierre Gantner, Laurent Cotte, Clotilde Allavena, Firouzé Bani-Sadr, Thomas Huleux, Claudine Duvivier, Marc-Antoine Valantin, Christine Jacomet, Véronique Joly, Antoine Chéret, Pascal Pugliese, Pierre Delobel, André Cabié, David Rey, Dat’AIDS Study Group
Published 2019-01-01

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

by Clotilde Allavena, Matthieu Hanf, David Rey, Claudine Duvivier, Firouze BaniSadr, Isabelle Poizot-Martin, Christine Jacomet, Pascal Pugliese, Pierre Delobel, Christine Katlama, Véronique Joly, Christian Chidiac, Nathalie Dournon, Dominique Merrien, Thierry May, Jacques Reynes, Amandine Gagneux-Brunon, Catherine Chirouze, Thomas Huleux, André Cabié, François Raffi, Dat’AIDS study group
Published 2018-01-01

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.

by Charline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, Georges Nembot, Adeline Mélard, Catherine Blanc, Caroline Lascoux-Combe, Laurence Slama, Thierry Allegre, Clotilde Allavena, Yazdan Yazdanpanah, Claudine Duvivier, Christine Katlama, Cécile Goujard, Bao Chau Phung Seksik, Anne Leplatois, Jean-Michel Molina, Laurence Meyer, Brigitte Autran, Christine Rouzioux, OPTIPRIM ANRS 147 study group
Published 2013-01-01